UBS Global Asset Management Bloomberg MSCI US Liquid Corp Sust UCITS ETF (USD) (UC98)
- Add to watchlist
- Create an alert
- This stock can be held in a
1,162.50p
1,162.50p
1,214.75p
London
1,162.25p
1,162.00p
1,140.00p
$596.2M
2.75p (0.24%) Previous:
2.75p
2,127
n/a
GBX
ETP Basics
Issuer: | UBS Asset Management |
---|---|
Structure: | ETF |
Replication method: | Stocks - Full Replication |
Securities lending: | No |
Number of holdings: | 450 |
Size: | $596.2M |
Launch date: | 23 July 2015 |
Launch price: | $15.62 |
UCITS: | Yes |
Reporting status: | Yes |
Domicile: | Luxembourg |
Complex product: | Non-complex |
ISIN: | LU1215461085 |
Annual & interim reports
Before you invest, please make sure you read the documents below
Ready to invest?
Important Documents
There are no documents available for this stock.
OBJECTIVE
Index: | Barclays MSCI US Liquid Corporates Sustainable Total Return |
---|---|
Aim: |
The UBS (Lux) Fund Solutions - Barclays MSCI US Liquid Corporates Sustainable UCITS ETF...
Read full aim for UBS Global Asset Management |
Leverage: | 100% |
Currency hedging: | No |
COSTS
Ongoing Charge (OCF/TER): | 0.13% |
---|---|
Management fee: | 0.13% |
Indicative spread: | 0.17% |
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
Performance
1 week 1W | 0.26% | 1 year 1Y | 0.34% |
---|---|---|---|
1 month 1M | 0.94% | 2 years 2Y | 7.17% |
3 months 3M | 0.75% | 3 years 3Y | 13.03% |
6 months 6M | 1.69% | 5 years 5Y | 16.9% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Security | Weight |
---|---|
Pfizer Investment Enterprises Pte Ltd | 0.83% |
Bank Of America Corp | 0.75% |
Amgen Inc | 0.74% |
Warnermedia Holdings Inc | 0.73% |
Pfizer Investment Enterprises Pte Ltd | 0.70% |
Warnermedia Holdings Inc | 0.62% |
Goldman Sachs Group Inc | 0.59% |
Pfizer Investment Enterprises Pte Ltd | 0.59% |
Amgen Inc | 0.58% |
Amgen Inc | 0.57% |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.